BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects

NCT02648672 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: BPN14770
DRUG: Placebo

Sponsor

Tetra Discovery Partners